Repligen (RGEN) Cost of Revenue (2010 - 2026)

Repligen (RGEN) has 17 years of Cost of Revenue data on file, last reported at $86.0 million in Q1 2026.

• Cost of Revenue for Q1 2026 came in at $86.0 million, up 10.5% year-over-year; the trailing twelve-month figure through Mar 2026 was $359.6 million (changed 0.45% YoY), and the FY2025 annual result was $352.0 million, down 2.16% from the prior year.
• Cost of Revenue retreated to $86.0 million in Q1 2026 per RGEN's latest filing, from $94.1 million in the prior quarter.
• Over five years, Cost of Revenue peaked at $128.7 million in Q4 2024 and troughed at $76.4 million in Q1 2024.
• A 5-year average of $88.1 million and a median of $86.3 million in 2022 frame the typical range for Cost of Revenue.
• The sharpest annual moves came in 2024 and 2025: Cost of Revenue jumped 46.03% in 2024, then fell 26.9% in 2025.
• A 5-year view of Cost of Revenue shows it stood at $90.7 million in 2022, then dropped by 2.83% to $88.1 million in 2023, then jumped by 46.03% to $128.7 million in 2024, then slipped by 26.9% to $94.1 million in 2025, then decreased by 8.62% to $86.0 million in 2026.
• Business Quant data shows RGEN's Cost of Revenue at $86.0 million in Q1 2026, $94.1 million in Q4 2025, and $88.3 million in Q3 2025.